# A Rare Case of Adenocarcinoma of the Urethra

**Authors:** Muhammad Waqas Shafiq, Taha Ahmad, Rabbya Naseem, Aisha Asif, Khurram Mir

PMC · DOI: 10.7759/cureus.87610 · Cureus · 2025-07-09

## TL;DR

A rare case of high-grade urethral adenocarcinoma in a 37-year-old man is reported, with treatment choices and outcomes discussed.

## Contribution

This paper presents a rare clinical case of primary urethral adenocarcinoma with detailed diagnostic and treatment considerations.

## Key findings

- The patient was diagnosed with high-grade anterior urethral adenocarcinoma (T1 N0 Mx) after histopathological analysis.
- The patient opted for systemic chemotherapy instead of recommended surgical intervention.
- The case highlights the aggressive nature and diagnostic challenges of primary urethral adenocarcinoma.

## Abstract

Primary urethral adenocarcinoma is a rare and aggressive subtype of primary urethral carcinoma. We report the case of a 37-year-old man with a three-month history of painless hematuria. An initial superficial biopsy revealed poorly differentiated carcinoma with squamous features, but further histopathology after transurethral resection confirmed high-grade anterior urethral adenocarcinoma (T1 N0 Mx) without regional or distant metastasis. After multidisciplinary discussion, urethrectomy with perineal urethrostomy was recommended; however, the patient declined surgery and chose systemic cisplatin-gemcitabine chemotherapy instead.

## Linked entities

- **Chemicals:** cisplatin (PubChem CID 5460033), gemcitabine (PubChem CID 60750)
- **Diseases:** adenocarcinoma (MONDO:0004970), urethral carcinoma (MONDO:0021327)

## Full-text entities

- **Diseases:** carcinoma (MESH:D009369), Primary urethral adenocarcinoma (MESH:D000230), Adenocarcinoma of the Urethra (MESH:D014523), hematuria (MESH:D006417)
- **Chemicals:** cisplatin (MESH:D002945), gemcitabine (MESH:D000093542)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12333902/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12333902/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12333902/full.md

---
Source: https://tomesphere.com/paper/PMC12333902